Xact Kapitalforvaltning’s Emergent Biosolutions EBS Stock Holding History

Xact Kapitalforvaltning’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$446K	Hold	7,709	–	–	0.01%	817
2019 Q4	$416K	Hold	7,709	–	–	0.01%	1081
2019 Q3	$403K	Hold	7,709	–	–	0.01%	1042
2019 Q2	$372K	Hold	7,709	–	–	0.01%	1098
2019 Q1	$389K	Hold	7,709	–	–	0.01%	1073
2018 Q4	$457K	Sell	7,709 -1,600	-17%	-$103K	0.01%	947
2018 Q3	$613K	Hold	9,309	–	–	0.01%	822
2018 Q2	$470K	Buy	9,309 +2,800	+43%	+$146K	0.01%	974
2018 Q1	$343K	Buy	6,509 +800	+14%	+$39.9K	0.01%	1133
2017 Q4	$265K	Buy	+5,709	New	+$240K	0.01%	1027

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Xact Kapitalforvaltning's EBS Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Emergent Biosolutions (EBS) position steady in Q1 2020 at 7,709 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #817.

Xact Kapitalforvaltning first reported a position in EBS in Q4 2017 and has held it in 10 quarters since. The position peaked at $613K in Q3 2018. 263 funds tracked by Wall St. Rank hold EBS as of Q1 2020.

Xact Kapitalforvaltning held 7,709 shares of Emergent Biosolutions worth $446K as of Q1 2020.
Xact Kapitalforvaltning left its Emergent Biosolutions share count unchanged in Q1 2020.
Emergent Biosolutions made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #817 holding.
Xact Kapitalforvaltning first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's Emergent Biosolutions position peaked at $613K in Q3 2018.
263 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.